Key result
High-risk non-cardiac surgery 1-12 months after DES implantation was associated with increased 30-day MACE compared to low-risk surgery (3.4% vs 0.6%; OR 5.8; 95% CI 1.7-20.1).
Why the study?
Does the ESC/ESA risk model accurately predict 30-day perioperative cardiac risk in patients undergoing non-cardiac surgery 1-12 months after DES implantation?
Population
4046 patients who underwent non-cardiac surgery 1-12 months after PCI with DES, median age 68 years, more…
Design
Editorial
Follow-up
30 days
Authors
Loading...
The ESC/ESA non-cardiac surgery risk score provides a simple and robust estimation of 30-day perioperative cardiac risk in patients undergoing non-cardiac surgery 1-12 months after DES implantation.
Does the ESC/ESA risk model accurately predict 30-day perioperative cardiac risk in patients undergoing non-cardiac surgery 1-12 months after DES implantation?
Odds Ratio: 5.8 (95% CI 1.7–20.1)
Absolute Event Rate: 3.4% vs 0.6%
The ESC/ESA non-cardiac surgery risk score provides a simple and robust estimation of 30-day perioperative cardiac risk in patients undergoing non-cardiac surgery 1-12 months after DES implantation.
Bing et al. (2018) conducted an editorial in Non-cardiac surgery after coronary drug-eluting stent implantation (n=4,046). High-risk non-cardiac surgery (ESC/ESA model) vs. Low-risk non-cardiac surgery was evaluated on Cardiac death and myocardial infarction (MACE) at 30 days (OR 5.8, 95% CI 1.7-20.1). High-risk non-cardiac surgery 1-12 months after DES implantation was associated with increased 30-day MACE compared to low-risk surgery (3.4% vs 0.6%; OR 5.8; 95% CI 1.7-20.1).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: